HIV subtype is a better predictor than viral load for determining rapid death from AIDS

Key points
- Johns Hopkins scientists say an infected person's HIV subtype is a better predictor than viral load for determining rapid death from AIDS.
- In what is believed to be the first analysis of viral subtype as a predictor of death from AIDS, which also takes into account viral load, the Hopkins team found that having viral subtype D made a person with HIV likely to die more rapidly compared to a person with subtype A.
- Ten percent of those infected with subtype D died within three years, while none with subtype A died.
- Participants in the study came from the Rakai cohort, a population of 12,000 people in Uganda who are being monitored to determine how HIV spreads throughout the country.
Johns Hopkins scientists say an infected person's HIV subtype is a better predictor than viral load for determining rapid death from AIDS.
Traditional testing standards help monitor the progression of an HIV infection to AIDS by keeping track of viral load, using a scale in which less than 50 viral particles per cubic milliliter of blood is considered suppressed disease and a viral load of more than 75,000 particles per cubic milliliter of blood means that the disease will progress more rapidly.
In what is believed to be the first analysis of viral subtype as a predictor of death from AIDS, which also takes into account viral load, the Hopkins team found that having viral subtype D made a person with HIV likely to die more rapidly compared to a person with subtype A.
Ten percent of those infected with subtype D died within three years, while none with subtype A died. However, viral load ranged from 20,000 particles per cubic milliliter of blood to 100,000 particles per cubic milliliter of blood in those with both subtypes, and was not found to be an accurate predictor of rapid death within the same timeframe.
Participants in the study came from the Rakai cohort, a population of 12,000 people in Uganda who are being monitored to determine how HIV spreads throughout the country. More than 300 newly infected men and women participated in the study, conducted between 1995 and 2001, with 53 becoming infected with subtype A and 203 infected with subtype D. Another 70 were infected with a recombinant version of both subtypes. Even though the quantity of virus infecting these individuals was roughly the same for each subtype, average years of survival for each subtype differed widely: 8.8 years for A, 6.9 years for D and 5.8 years for AD.
Through annual blood tests, which were part of the study, the researcher knew when each person became infected. Once the diagnosis was confirmed, researchers used DNA tests to determine the HIV subtype, A and D being the most common in Uganda.
Researchers believe that subtype D is more virulent than subtype A because D has the ability to bind to key receptors on immune cells, allowing subtype D to kill more quickly. Additional blood analysis showed that with subtype A, the virus bound only to one kind of receptor, CCR5, to infect the cell. But 25 percent of subtype D virus bound to both CCR5 and another receptor, CXCR4. Indeed, two-thirds of those infected with CXCR4-binding virus died within three years.
According to the study's lead researcher, Oliver Laeyendecker, M.S., M.B.A., a senior research associate at The Johns Hopkins University School of Medicine and senior research assistant at the National Institute of Allergy and Infectious Disease, "Knowing a person's HIV subtype is important for the management of the infection because the disease can progress more rapidly in those infected with subtype D and recombinant virus incorporating subtype D than in those with other subtypes."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsBuilding better HIV antibodies
Using highly potent antibodies isolated from HIV-positive people, researchers have recently begun to identify ways to broadly neutralize the many possible subtypes of HIV. Now, a team led by biologists at the California…
29 October 2011
NewsAlcohol impairs the body's ability to fight off viral infection
Alcohol is known to worsen the effects of disease, resulting in longer recovery period after trauma, injury or burns. It is also known to impair the anti-viral immune response, especially in the liver, including…
1 October 2011
NewsAntiretroviral treatment is HIV prevention: The proof is here
A special press conference at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) will today feature a panel consisting of researchers from the CDC TDF2 study, the Partners PrEP Study and the…
19 July 2011

